Evidence map›Paper›PMID 31974491›Full record

ReviewNature reviews. Cancer2020

Nerves in cancer.

Ali H Zahalka, Paul S Frenette

Registry-linked trialAbstract readReview
In one paragraph

Review in Nature reviews. Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07187284 (Evaluating Endervascular Denervation), which is not on this map. Cited by 305 papers.

0numbers the graph read from it
0cells of the map it votes in
305citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07187284 phase1 / phase2not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Evaluating Endervascular Denervation (EDN) Combined With Transarterial Intervention (TACE/HAIC) and Second-Line Immune-Targeted Therapy in Locally Advanced Hepatocellular Carcinoma (HCC) With Portal Vein Tumor Thrombosis After Progression on First-Line Systemic Therapy: A Prospective, Multicenter, Randomized Controlled Study

TypeinterventionalSponsorZhongda HospitalRan2025 to 2027Enrolled62ConditionsHCC - Hepatocellular CarcinomaArmsEDN combined with TACE/HAIC and Immuno-Targeted Therapy, TACE/HAIC plus Immuno-Targeted Therapy
3 · Its place in the literature

Who cites it

305 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review

245 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ali H ZahalkaRuth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0001-5574-3467
Paul S FrenetteRuth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, New York, NY, USA. paul.frenette@einsteinmed.org.ORCID http://orcid.org/0000-0003-0862-9922

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007288 · NIGMS · YESHIVA UNIVERSITY · PI AKABAS, MYLES H. · 1985 to 2022
$35.6M
In Vivo Sickle Cell Vasoocclusion: Adhesion MechanismsR01HL069438 · NHLBI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI KELLY, LIBUSHA · 2001 to 2024
$9.5M
Regulation and function of hematopoietic stem cell nichesR01DK056638 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI GRITSMAN, KIRA · 2000 to 2023
$8.7M
Molecular NeuropathologyT32NS007098 · NINDS · YESHIVA UNIVERSITY · PI SANTAMBROGIO, LAURA · 1985 to 2015
$5.0M
Mechanisms mediating circadian oscillations of leukocyte migrationR01HL097700 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FRENETTE, PAUL S · 2009 to 2012
$1.7M
Evaluating neural circuitry of the bone marrowU01DK116312 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI FRENETTE, PAUL S · 2017 to 2019
$1.3M
Contributions of sympathetic signals to prostate cancer progression.F30CA203446 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ZAHALKA, ALI · 2016 to 2018
$143k
NCI NIH HHS F30 CA203446NHLBI NIH HHS R01 HL069438NHLBI NIH HHS R01 HL097700NIDDK NIH HHS R01 DK056638NIDDK NIH HHS U01 DK116312NIGMS NIH HHS T32 GM007288NINDS NIH HHS T32 NS007098
6 · The paper itself

Abstract

The contribution of nerves to the pathogenesis of malignancies has emerged as an important component of the tumour microenvironment. Recent studies have shown that peripheral nerves (sympathetic, parasympathetic and sensory) interact with tumour and stromal cells to promote the initiation and progression of a variety of solid and haematological malignancies. Furthermore, new evidence suggests that cancers may reactivate nerve-dependent developmental and regenerative processes to promote their growth and survival. Here we review emerging concepts and discuss the therapeutic implications of manipulating nerves and neural signalling for the prevention and treatment of cancer.

Indexed as

Signal TransductionTumor MicroenvironmentAnimalsAutonomic PathwaysDisease ManagementDisease SusceptibilityHumansNeoplasmsNeuroimmunomodulationNeurotransmitter AgentsSynaptic TransmissionNeurotransmitter Agents

Identifiers

PMID31974491
PMCPMC7709871

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.